Literature DB >> 15077914

Somatostatin receptor distribution and function in immune system.

D Ferone1, P M van Hagen, C Semino, V A Dalm, A Barreca, A Colao, S W J Lamberts, F Minuto, L J Hofland.   

Abstract

Somatostatin and cortistatin, a recently discovered endogenous neuropeptide relative of somatostatin, have multiple modulatory effects on the immune system. The specific somatostatin receptor distribution might in part explain the heterogeneity of effects of somatostatin or its analogs on immunocytes. In fact, somatostatin receptor subtypes are differentially expressed on specific cell subsets within the organs of the immune system and the expression is dynamically regulated and seems to depend on the traffic of these cells through and within lymphoid structure and homing in tissues. Somatostatin effects on immune cells are mainly based on autocrine and paracrine modes of action. In fact, activated cells producing somatostatin (or cortistatin) may interact with other cells expressing the receptors. Here, we review the postulated modes of action of somatostatin and somatostatin-like peptides, including the currently available synthetic somatostatin analogs, in cells of the immune system. We also discuss the wide distribution of somatostatin and its specific five receptor subtypes in immune cell lines, as well as throughout animal and human lymphoid organs, in both normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077914     DOI: 10.1016/j.dld.2003.11.020

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

Review 1.  Imaging Pulmonary Inflammation.

Authors:  Philip M Scherer; Delphine L Chen
Journal:  J Nucl Med       Date:  2016-09-01       Impact factor: 10.057

2.  Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphy.

Authors:  D Ferone; R Pivonello; D J Kwekkeboom; F Gatto; P Ameri; A Colao; R R de Krijger; F Minuto; S W J Lamberts; P M van Hagen; L J Hofland
Journal:  J Endocrinol Invest       Date:  2011-07-13       Impact factor: 4.256

Review 3.  Overview of positron emission tomography in functional imaging of the lungs for diffuse lung diseases.

Authors:  Avanti V Gulhane; Delphine L Chen
Journal:  Br J Radiol       Date:  2021-11-09       Impact factor: 3.629

4.  Somatostatin and cancer: applying endocrinology to oncology.

Authors:  Adda Grimberg
Journal:  Cancer Biol Ther       Date:  2004-08-23       Impact factor: 4.742

5.  Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer.

Authors:  Katalin Leiszter; Ferenc Sipos; Orsolya Galamb; Tibor Krenács; Gábor Veres; Barna Wichmann; István Fűri; Alexandra Kalmár; Árpád V Patai; Kinga Tóth; Gábor Valcz; Zsolt Tulassay; Béla Molnár
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

6.  Role of high mobility group box-1 and protection of growth hormone and somatostatin in severe acute pancreatitis.

Authors:  Y F Wang; M Wu; B J Ma; D A Cai; B B Yin
Journal:  Braz J Med Biol Res       Date:  2014-09-12       Impact factor: 2.590

Review 7.  Immunomodulatory Role of Neuropeptides in the Cornea.

Authors:  Sudan Puri; Brendan M Kenyon; Pedram Hamrah
Journal:  Biomedicines       Date:  2022-08-16

8.  Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells.

Authors:  Céline Kerros; Thibault Cavey; Brigitte Sola; Philippe Jauzac; Stéphane Allouche
Journal:  J Exp Clin Cancer Res       Date:  2009-06-07

9.  Tumoral prostate shows different expression pattern of somatostatin receptor 2 (SSTR2) and phosphotyrosine phosphatase SHP-1 (PTPN6) according to tumor progression.

Authors:  Ariel Ernesto Cariaga-Martinez; María Angelica Lorenzati; Mario Alejandro Riera; Marisa Angelica Cubilla; Andrés De La Rossa; Ernesto Martín Giorgio; María Mercedes Tiscornia; Esteban Mariano Gimenez; María Eugenia Rojas; Bárbara Julieta Chaneton; Dora Isabel Rodríguez; Pedro Darío Zapata
Journal:  Adv Urol       Date:  2009-04-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.